Alex Schwartz
Stock Analyst at Stifel
(1.81)
# 3,180
Out of 4,944 analysts
11
Total ratings
25%
Success rate
9.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Alex Schwartz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANAB AnaptysBio | Initiates: Buy | $50 | $20.23 | +147.16% | 4 | Feb 21, 2024 | |
| VTVT vTv Therapeutics | Downgrades: Hold | n/a | $15.33 | - | 2 | Apr 10, 2018 | |
| GERN Geron | Maintains: Hold | $2.5 → $4 | $1.44 | +178.75% | 1 | Mar 19, 2018 | |
| PBYI Puma Biotechnology | Maintains: Buy | $85 → $95 | $5.41 | +1,656.01% | 4 | Mar 9, 2018 |
AnaptysBio
Feb 21, 2024
Initiates: Buy
Price Target: $50
Current: $20.23
Upside: +147.16%
vTv Therapeutics
Apr 10, 2018
Downgrades: Hold
Price Target: n/a
Current: $15.33
Upside: -
Geron
Mar 19, 2018
Maintains: Hold
Price Target: $2.5 → $4
Current: $1.44
Upside: +178.75%
Puma Biotechnology
Mar 9, 2018
Maintains: Buy
Price Target: $85 → $95
Current: $5.41
Upside: +1,656.01%